2′ Biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling

Optimization and further SAR exploration of the biaryl amide series resulted in the discovery of orally bioavailable, CNS-penetrant M1 agonists with excellent potency and subtype selectivity.